- Phase II trial of trimetrexate in the treatment of recurrent childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. Pappo, A., Dubowy, R., Ravindranath, Y., Alvarado, C., Rao, S., Whitehead, V.M., Vega, R., Kamen, B., Vietti, T. J. Natl. Cancer Inst. (1990)









